Hi, welcome to my page. My name is Nishanth Merwin and I'm currently at QuartzBio solving problems around clinical trial data operations. In my day-to-day, I wear a lot of hats ranging from software engineering, product management and data science. Previously, I worked at early stage drug discovery companies (like Adapsyn and BioSymetrics) where I applied machine learning to uncover new therapeutics. I completed graduate research under Nathan Magarvey where I built AI/ML strategies for integrating multiomic data towards the goal of accelerating drug discovery (e.g. DeepRiPP).
I'm always happy to chat about the intersection of software engineering, machine learning and drug discovery.
Merwin NJ, Mousa WK, Dejong CA, Skinnider MA, Cannon MJ, Li H, Dial K, Gunabalasingam M, Johnston CW, Magarvey NA. Proceedings of the National Academy of Sciences 2020; doi:10.1073/pnas.1901493116
Skinnider MA, Johnston CW, Merwin NJ, Dejong CA, Magarvey NA. Global analysis of prokaryotic tRNA-derived cyclodipeptide biosynthesis. BMC Bioinformatics 2018; doi:10.1186/s12864-018-4435-1
Skinnider MA, Johnston CW, Merwin NJ, Dejong CA, Magarvey NA. Global analysis of prokaryotic tRNA-derived cyclodipeptide biosynthesis. BMC Bioinformatics 2018; doi:10.1186/s12864-018-4435-1
Mousa WK, Athar B, Merwin NJ, Magarvey NA. Antibiotics and specialized metabolites from the human microbiota. Natural Product Reports 2017; doi:10.1039/c7np00021a
Skinnider MA, Merwin NJ, Johnston CW, Magarvey NA. PRISM 3: expanded prediction of natural product chemical structures from microbial genomes. Nucleic Acids Research 2017; doi:10.1093/nar/gkx320
Skinnider MA, Johnston CW, Edgar RE, Dejong CA, Merwin NJ, Rees PN, et al. Genomic charting of ribosomally synthesized natural product chemical space facilitates targeted mining. Proceedings of the National Academy of Sciences 2016; doi:10.1073/pnas.1609014113